Derek Mangoya

Dr. Derek Mangoya

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Tafadzwa DzinamariraTafadzwa Dzinamarira
Tafadzwa Dzinamarira
GRGallican N. Rwibasira
Gallican N. Rwibasira
LMLoveday Mwila
Loveday Mwila
Enos MoyoEnos Moyo
Enos Moyo
DMDerek Mangoya
Derek Mangoya
Claude Mambo MuvunyiClaude Mambo Muvunyi
Claude Mambo Muvunyi
Sub-Saharan Africa continues to bear a disproportionate burden of the global HIV epidemic. Integrating HIV services into primary healthcare is a crucial strategy to accelerate progress towards ending the epidemic. However, several challenges hinder effective integration, including underfunding, human resource shortages, infrastructure limitations, weak health systems, and sociocultural factors. With this perspective, we discuss strategies to address these challenges. A comprehensive, multi-faceted approach is necessary to overcome these barriers. Investing in human resources, improving infrastructure, and strengthening health information systems are essential for strengthening the health system. Implementing patient-centered care, integrated service delivery models, and community engagement can optimize service delivery. Utilizing digital health tools, such as mobile health applications and electronic health records, can enhance service delivery and data management. Mobilizing for an increase in domestic resources, aligning donor funding, and using cost-effective approaches are crucial for effective financing. Finally, robust monitoring and evaluation systems are necessary to track progress, identify challenges, and inform decision-making. With these strategies, among many others, sub-Saharan African countries can significantly improve the integration of HIV services into primary healthcare, leading to better health outcomes for people living with HIV and more sustainable HIV programs.

6 October 2023 in Journal of Infection and Public Health
Verified
Journal Article
Open access
Enos MoyoEnos Moyo
Enos Moyo
MCMunashe Chimene
Munashe Chimene
PMPerseverance Moyo
Perseverance Moyo
Godfrey MusukaGodfrey Musuka
Godfrey Musuka
DMDerek Mangoya
Derek Mangoya
Tafadzwa DzinamariraTafadzwa Dzinamarira
Tafadzwa Dzinamarira
COVID-19-related complications can last for years, even in patients who are asymptomatic during the acute phase, a phenomenon referred to as long COVID. This scoping review aimed to summarize the risk factors and clinical symptoms of long COVID in Africa between 2020 and 2022. Five studies were included. Three of the studies used in this review were retrospective cross-sectional studies, one was a prospective cohort study while another one was a case-control study. The review identified several risk factors for long COVID, including being female, being older than 40 years, having more than four acute COVID-19 symptoms, and having concomitant conditions such as asthma, hypertension, and depression. General, respiratory, cardiovascular, otolaryngological, gastrointestinal, and neurological symptoms were among the reported long COVID symptoms. To ensure that patients with long COVID are diagnosed and treated early, the risk factors and clinical symptoms of long COVID need to be identified for different population groups.

26 September 2023 in IJID Regions
Verified
Journal Article
Open access
DMDerek Mangoya
Derek Mangoya
Enos MoyoEnos Moyo
Enos Moyo
GMGrant Murewanhema
Grant Murewanhema
PMPerseverance Moyo
Perseverance Moyo
ICItai James Chitungo
Itai James Chitungo
Tafadzwa DzinamariraTafadzwa Dzinamarira
Tafadzwa Dzinamarira
• Authors explored successes in HIV response pre and during COVID-19. • HIV anti-retroviral therapy coverage, differentiated HIV service delivery models, and technological innovations are discussed. • Tailored approaches for sustainable health systems strengthening are discussed.

26 January 2025 in Venereology
Verified
Journal Article
Open access
PDF file
Enos MoyoEnos Moyo
Enos Moyo
PMPerseverance Moyo
Perseverance Moyo
LBLeela Barham
Leela Barham
DMDerek Mangoya
Derek Mangoya
MMMalizgani MHANGO
Malizgani MHANGO
Tafadzwa DzinamariraTafadzwa Dzinamarira
Tafadzwa Dzinamarira
The World Health Organization (WHO) recommended the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention in 2015. Although the number of countries with national PrEP recommendations increased from 2 in 2015 to 121 in 2019, there has been slow progress in Africa. The reason for this slow progress is that developing countries have budgetary constraints. Budget impact analysis (BIA) is an economic analysis that can help explore the affordability of oral PrEP. A rapid review was conducted to summarise the existing literature on the budget impact of adopting oral PrEP for HIV prevention. PubMed and Google Scholar databases were searched for relevant studies. Studies included in the review utilised primary data. Eleven studies met the inclusion criteria. This review reveals that most studies took a healthcare service provider perspective, targeted men who have sex with men (MSM), had time horizons of more than 10 years, used macro-costing, and performed univariate sensitivity analysis and discounting. If countries wish to perform a budget impact analysis of adopting oral PrEP for HIV prevention, we recommend that they select a target population that is most at risk of acquiring HIV. In addition, a time horizon of ten years or more should be used, and accurate values of the cost of oral PrEP and antiretroviral therapy (ART) and adherence to oral PrEP should be researched. Furthermore, deterministic sensitivity analysis should be carried out instead of probabilistic sensitivity analysis (PSA), as the degree of variability and the extent of the correlation among the parameters may not be known.